Formulation Pharmacist | R&D Pharmaceutical Development
─────────────────────────
I develop medicines — from the first lab trial to the final product on the shelf.
With experience from 2022 GMP-regulated R&D, I specialise in formulation and
process development across a broad range of dosage forms: oral solids (tablets,
HGCs, POS, sachets), liquids, parenteral (lyophilized, beta-lactam, non-beta-lactam), and ophthalmic preparations.
My work spans the full development lifecycle — pre-formulation, experimental trials,
ICH stability studies, scale-up, technology transfer, and regulatory documentation
(DMF, CTD, SOPs, batch records) — always in close collaboration with production and QA/QC teams.
What sets me apart: hands-on experience in reverse engineering and multi-site
technology transfer across products of varying complexity and scale.
──────────────────────────
CORE EXPERTISE
──────────────────────────
▸ Solid & liquid oral · Parenteral · Ophthalmic formulation
▸ Pre-formulation & physicochemical characterization
▸ Reverse engineering of reference products
▸ ICH stability: stress · accelerated · long-term
▸ Scale-up and down, pilot batches & technology transfer
▸ DMF · CTD · SOP · batch record authorship
▸ GMP / GLP multi-site compliance